Given that amphiregulin was dynamically elevated in some cases of sepsis without a CRP rise and vice versa, we hypothesized that development of a test for sepsis that combined both parameters would increase test accuracy to ‘rule-out’ sepsis. This evidence concerns the gene CRP and Sepsis.